Premium
TIMOLOL MALEATE—A PROMISING NEW BETA ADRENERGIC BLOCKER FOR GLAUCOMA
Author(s) -
O'Day Denis M.,
Batchelor E. Dale,
Wood Alastair J. J.,
Shand David G.
Publication year - 1979
Publication title -
australian journal of opthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.3
H-Index - 74
eISSN - 1442-9071
pISSN - 0310-1177
DOI - 10.1111/j.1442-9071.1979.tb01455.x
Subject(s) - timolol , intraocular pressure , glaucoma , medicine , pharmacology , adrenergic beta antagonists , blood pressure , sympatholytics , eye drop , beta blocker , chemistry , ophthalmology , propranolol , anesthesia , heart failure
Summary The pharmacology and clinical effects of timolol maleate, an adrenergic beta‐blocking agent, are discussed. Timolol maleate appears to exert its action by reducing aqueous production. It produces a significant drop in intraocular pressure of prolonged duration and is remarkably free from side effects. The systemic preparation reduces both intraocular pressure and systemic blood pressure.